Fig. 2
From: Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1
Pan-cancer Analysis of MEOX1 Expression in various cancer types. A The mRNA expression of MEOX1 in a wide array of TCGA cancer types from the UALCAN portal. B The relative mRNA expression level of MEOX1 in various cancer types from the Oncomine; *P < 0.05 vs. Kidney Cancer. C The relative mRNA level of MEOX1 across multi-cancer cells derived from the CCLE database. D The relative mRNA expression level of MEOX1 in multi-cancer cells from the Oncomine; *P < 0.05 vs. Melanoma. E The relative mRNA level of MEOX1 in pan-cancer tumor tissues (red columns) and the corresponding TCGA normal controls (blue columns) from the TIMER.2.0 database; *P < 0.05, **P < 0.01, ***P < 0.001 vs. normal controls. F The mRNA expression of MEOX1 in tumor tissues (red columns) and matched GTEx normal tissues (grey columns) of DLBC, OV, and SKCM as analyzed by the GEPIA2.0; *P < 0.05